Ser544

Site Information
VItVLtRsKRKGSAR SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 31869511

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	breast cancer ( 2 )
Relevant cell line - cell type - tissue:	BT-549 (breast cell) ( 2 ) , HeLa (cervical) ( 1 , 3 ) , MDA-MB-231 (breast cell) ( 2 )

References
1	Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94 25159151 Curated Info
2	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info
3	Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5 21712546 Curated Info